Kenvue reported second-quarter revenue and adjusted earnings that topped expectations Thursday in the consumer health company's first quarterly report since it spun out from Johnson & Johnson two months ago.
But J&J still owns a 90% stake in Kenvue, meaning it can generally control the direction of the spinoff's business for now.
Excluding certain items, the company's adjusted earnings were 32 cents a share.
The company's full-year adjusted earnings outlook is $1.26 to $1.31 per share.
The company reported sales growth across its three business divisions in the second quarter.
Persons:
Kenvue, Johnson, Kenvue's, Thibaut Mongon, headwinds, Mongon
Organizations:
Johnson, Refinitiv, Deutsche Bank Global Consumer Conference
Locations:
Kenvue, Canada